Hypersomnias of central origin
99 important questions on Hypersomnias of central origin
What are the primary central disorders of hypersomnolence?
- Narcolepsy (especially Narcolepsy type 1 (NT1))
- Idiopathic hypersomnia
- Kleine-Levin syndrome (KLS)
- NT1 is characterized by hypocretin deficiency.
What issues affect the availability of epidemiological data on hypersomnolence disorders?
- Unspecific definitions
- Lack of biomarkers for certain disorders
- Available data primarily for Narcolepsy type 1 (NT1)
- General population estimated prevalence up to 5%.
How is excessive daytime sleepiness (EDS) defined?
- Chronic sleepiness (>3 months) during wake hours
- Irresistible need for sleep during the day
- Possible unintended sleep attacks
- Impaired vigilance or attention.
- Higher grades + faster learning
- Never study anything twice
- 100% sure, 100% understanding
What differentiates idiopathic hypersomnia (IH) from narcolepsy?
- Chronic EDS without cataplexy
- No REM sleep dysregulation
- Long sleep times may be present
- Diagnosis revised in ICSD-3 criteria for better accuracy.
What is a key characteristic of Kleine-Levin syndrome?
- Episodes of hypersomnia lasting 1-4 weeks
- Neuropsychiatric abnormalities during episodes
- Alternating asymptomatic periods
- Menstrual-related form occurring in women.
What causes hypersomnia due to medical disorders?
- Parkinson’s disease (20%-40% affected)
- Central nervous system lesions (e.g., strokes, brain tumors)
- Traumatic brain injuries
- Genetic disorders like myotonic dystrophy.
What are the primary central disorders of hypersomnolence?
- Narcolepsy
- Idiopathic hypersomnia
- Kleine-Levin syndrome (KLS)
- Only narcolepsy with cataplexy (type 1, NT1) has hypocretin as a biomarker.
How is narcolepsy type 1 (NT1) characterized?
- Chronic excessive daytime sleepiness (EDS)
- Presence of cataplexy
- Sleep onset REM sleep episodes (SOREMs)
- Hypocretin deficiency
What defines narcolepsy type 2 (NT2)?
- Excessive daytime sleepiness (EDS)
- Sleep onset REM sleep episodes (SOREMs)
- Absence of cataplexy
- No decrease in cerebrospinal fluid hypocretin levels
What distinguishes idiopathic hypersomnia (IH) from narcolepsy?
- Chronic excessive daytime sleepiness (EDS)
- Absence of cataplexy
- No REM sleep dysregulation
- Typical features include long sleep times and sleep drunkenness
What is Kleine-Levin syndrome characterized by?
- Episodes of hypersomnia lasting 1-4 weeks
- Alternating periods of neuropsychiatric abnormalities
- Asymptomatic periods
- A subtype related to menstruation in women
What can cause hypersomnia due to a medical disorder?
- Chronic excessive daytime sleepiness (EDS)
- Various etiologies lead to symptoms
- Conditions like Parkinson's disease and stroke
- Severity and manifestations can vary significantly
How common is insufficient sleep syndrome compared to narcolepsy type 1 (NT1)?
- Insufficient sleep syndrome is 5-10 times more frequent than NT1
- NT2 and idiopathic hypersomnia are 3-10 times less common
- Up to 5% of the general population may have hypersomnolence disorders
What are the diagnostic challenges of narcolepsy type 2 (NT2)?
- Often lacks other biomarkers for accurate diagnosis
- False positives can occur
- Insufficient sleep syndrome may mimic severe symptoms
What classifications exist for hypersomnolence disorders?
- American Psychiatric Association (DSM-V)
- American Academy of Sleep Medicine (ICSD-3)
- Various national sleep and neurological societies
- ICSD-3 is the most widely used classification
How does the International Classification of Sleep Disorders (ICSD-3) categorize hypersomnolence disorders?
- Includes narcolepsy types 1 and 2
- Idiopathic hypersomnia
- Kleine-Levin syndrome, among others
- Criteria based on expert consensus and scientific evidence
What are the central origin hypersomnias mentioned in the summary?
- Narcolepsy type 1 (with cataplexy)
- Narcolepsy type 2 (without cataplexy)
- Idiopathic hypersomnia
- Kleine-Levin syndrome
- Hypersomnia due to medical disorders
- Hypersomnia due to medication or substance
- Hypersomnia with psychiatric disorders
- Insufficient sleep syndrome
What is the difference between excessive daytime sleepiness (EDS) and excessive need for sleep (ENS)?
- EDS is inability to stay awake causing sleep attacks
- ENS involves a need for excessive sleep duration (>11 hours)
- Both symptoms may affect daily performance
What role does cataplexy play in diagnosing narcolepsy type 1?
- It helps differentiate NT1 from other conditions.
- It is the only specific symptom of narcolepsy.
- The presence indicates possible narcolepsy diagnosis.
What are the key features of hypersomnolence disorders?
- Chronic excessive daytime sleepiness (EDS)
- Excessive need for sleep (ENS)
- Increased sleep quantity over 24 hours
- Associated impairment in quality of life
What distinguishes narcolepsy type 1 and type 2 in clinical diagnosis?
- Type 1 (NT1): presence of cataplexy
- Type 2 (NT2): absence of cataplexy
- Both types exhibit excessive daytime sleepiness (EDS).
How does the DSM-V define hypersomnia?
- Defined as sleep duration greater than 9 hours
- Lacks biomarkers for accurate diagnosis
- Does not distinguish between different narcolepsy types
How is excessive daytime sleepiness (EDS) characterized in narcolepsy?
- Often overwhelming and irresistible.
- Develops over weeks to months.
- May occur in monotonous situations (watching TV, reading).
- Can lead to sleep attacks even during activities.
What are Central Disorders of Hypersomnolence (CDH) primarily characterized by?
- Excessive daytime sleepiness (EDS)
- Associated sleep symptoms
- Biological factors such as human leukocyte antigen and cerebrospinal hypocretin-1 levels
- Non-sleep-related symptoms contributing to disease burden
What factors contribute to the understanding of central disorders of hypersomnolence (CDH)?
- Integration of human and animal model data
- Neurochemical factors: impaired hypocretin, dopamine, noradrenaline, histamine, serotonin
- Genetic and environmental influences
- Immune-mediated loss of hypocretin neurons in narcolepsy
What clinical features are associated with cataplexy in narcolepsy?
- Sudden, bilateral loss of muscle tone
- Triggered by emotions, especially mirth
- Preserved consciousness during episodes
- Symptoms may vary from face drooping to weakness.
What pharmacological treatments are recommended for excessive daytime sleepiness (EDS) in narcolepsy?
- First-line: modafinil, pitolisant, solriamfetol
- Second-line: methylphenidate
- Third-line: combination of drugs, or amphetamines
- Antidepressants for cataplexy and sodium oxybate for REM symptoms.
What learning objectives are highlighted in relation to CDH?
- Awareness of atypical EDS manifestations and cognitive complaints
- Understanding of their impact on quality of life and socioeconomic burden
- Review of tools for subjective symptom assessment
How is cataplexy related to narcolepsy in terms of neurochemistry?
- Severe hypocretin deficiency
- Altered activation of brain circuits
- Associated with REM sleep disturbances
- Pathognomonic for narcolepsy type 1
What are common sleep disturbances in narcolepsy?
- Sleep-disordered breathing (SDB)
- Periodic limb movements during sleep (PLMS)
- Rapid eye movement (REM) sleep behavior disorder (RBD)
- Sleep fragmentation without increased total sleep time.
What factors should be considered when selecting treatments for narcolepsy?
- Presence and severity of symptoms
- - Daytime sleepiness, cataplexy, hypnagogic hallucinations
- Patient characteristics
- - Age, gender, birth control method
- Comorbid conditions
- - Obesity, apneas, metabolic, cardiovascular, psychiatric
How does fatigue present in patients with CDH compared to EDS?
- Misinterpreted as EDS
- Defined by lack of energy
- Associated with poorer quality of life
- Correlated with depressive symptoms
What neuroanatomical findings support the pathophysiology of narcolepsy?
- Loss of hypocretin neurons in the lateral hypothalamus
- Increased histaminergic neurons in narcolepsy type 1
- Neuroimaging studies indicating metabolic changes in various brain regions
- Inconclusive results on morphological changes
What are the criteria for diagnosing narcolepsy type 1 (NT1)?
- Daily periods of irrepressible need to sleep for at least 3 months.
- Presence of cataplexy and sleep latency < 8 min.
- Hypocretin-1 level < 110 pg/ml measured in CSF.
How is modafinil characterized in terms of its use for narcolepsy?
- Wakefulness-promoting agent enhancing dopamine activity
- Recommended as first-line therapy
- Effective dosage: 200-400 mg/day
- Common side effects include headache, nervousness, and nausea.
What cognitive problems are commonly reported by patients with narcolepsy?
- Reduced attention and memory difficulties
- Impairment in executive functions
- Issues during sustained cognitive tasks
- Normal functioning on brief tasks
What characterizes excessive daytime sleepiness (EDS) in narcolepsy?
- Persistent drowsiness, often fluctuating
- Episodes of automatic behavior and sleep
- Correlation with REM sleep occurrences
- Potential primary deficiency in arousal systems
What psychiatric disturbances are commonly associated with narcolepsy?
- Anxiety
- Mild to moderate depression
- Social phobias
- Found in 20%-30% of narcolepsy cases.
How does pitolisant function as a treatment for narcolepsy?
- Acts as an inverse H3-receptor agonist
- Enhances histamine release, improving wakefulness
- Recommended dosage: 9-36 mg/day
- Effective with good tolerance profile after 1 year.
What educational challenges do patients with narcolepsy face?
- Reported problems in half of narcoleptic individuals
- 25% face unexpected school dropout
- Conflicting educational levels compared to non-narcoleptics
- Importance of early diagnosis for better academic outcomes
What factors are involved in the pathophysiology of cataplexy?
- Recruitment of brain mechanisms responsible for REM atonia
- Activation of brainstem elements and supratentorial structures
- Interaction with emotional and motor circuits
- Triggering by emotional stimuli
What are the primary types of central-origin hypersomnias?
- Narcolepsy with cataplexy (NT1)
- Narcolepsy without cataplexy (NT2)
- Idiopathic hypersomnia
- Kleine-Levin syndrome
- Hypersomnia due to medical disorders
- Hypersomnia associated with psychiatric disorders
- Insufficient sleep syndrome
What are the non-pharmacological management strategies for narcolepsy?
- Educating patients on their ailments
- Maintaining a healthy lifestyle
- Regular physical activity and weight control
- Scheduled short naps to boost daytime performance.
What are the socioeconomic impacts of hypersomnia disorders?
- Higher need for medical consultations
- Lower productivity and employment rates
- Increased absenteeism and early retirement
- Financial strain on patients and families
What is the primary focus of the summary regarding CDH?
- Integration of data from human and animal models
- Impaired hypocretin and aminergic neurotransmission
- Correlation of cataplexy with hypocretin deficiency
- Genetic and environmental factors involvement
What symptoms are typical of excessive daytime sleepiness (EDS)?
- Overwhelming sleepiness
- Inability to stay awake
- Concentration difficulties
- Sleep attacks during activities
- Brief and refreshing sleep episodes
- Fatigue and tiredness
- Automatic behaviors
What are the adverse effects associated with modafinil?
- Commonly mild and include:
- - Headache (13%)
- - Nervousness (8%)
- - Nausea (5%)
- Low potential for abuse and interactions with contraceptives.
How do chronic disorders affect health-related quality of life (HRQoL)?
- Affecting various life domains
- Suffering poorer scores in assessments like SF-36
- Correlating EDS severity with lower HRQoL
- Impacting perceptions through depressive feelings
What are the learning objectives related to narcolepsy?
- Aetiology of narcolepsy including hypocretin neurones loss
- Pathophysiological role of hypocretin and aminergic neurotransmission
- Recognition of biomarkers for CDH
What defines cataplexy in narcolepsy?
- Sudden bilateral loss of muscle tone
- Triggered by strong emotions
- Consciousness preserved during episodes
- Symptoms include face drooping and eyelid closure
- Can lead to falls in complete attacks
What is the importance of sleep hygiene in managing narcolepsy?
- Reduces sleep inertia and promotes better sleep quality
- Recommended behaviors include:
- - Avoiding sleep deprivation
- - Maintaining regular night-time sleep schedule
- - Taking short scheduled naps can reduce daytime sleepiness.
What is the main complaint associated with Central Disorders of Hypersomnolence (CDH)?
- Other sleep symptoms
- Sleep alterations (e.g., polysomnography)
- Biological factors (e.g., hypocretin-1 levels)
What are the typical triggers for cataplexy?
- Laughter (mirth)
- Other unexpected emotions
- Less common: anger
- Rarely involves pain or fear
What is the main pathophysiological feature of CDH?
- Insufficiency of arousal systems
- Deficient hypocretin and/or aminergic neurotransmission
- Less emphasis on sleep over-activity or disinhibition
What are characteristic symptoms of narcolepsy?
- Excessive daytime sleepiness (EDS)
- Cataplexy specific to narcolepsy type 1
- Disturbed night-time sleep, hypnagogic hallucinations, sleep paralysis.
- Symptoms can lead to significant disability and impact daily life.
What are common symptoms reported by patients with CDH?
- Tiredness
- Fatigue
- Poor concentration
- Their symptoms may complicate assessments and diagnosis.
How do cognitive complaints relate to CDH?
- Somnolence due to hypovigilance
- Genuine comorbid conditions
How is cataplexy related to narcolepsy?
- Pathognomonic for narcolepsy
- Correlation with severe hypocretin deficiency
- Arises from altered activation of specific brain circuits
What are common non-specific symptoms of narcolepsy?
- Sleep paralysis
- Hallucinations
- Sleep-disordered breathing
- Periodic limb movements during sleep
- Rapid eye movement sleep behavior disorder
What are the main non-pharmacological strategies recommended for narcolepsy management?
- Education about symptoms
- Good sleep hygiene
- Regular night-time sleep schedule
- Short scheduled naps
- Physical activity
- Weight control
What did von Economo suggest about narcolepsy's origin?
- Narcolepsy may originate from the hypothalamus
- This observation was based on studies in encephalitis lethargica
What tools are used for diagnosing hypersomnias of central origin?
- Patient history
- Sleep logs
- Actigraphy
- Polysomnography
- Multiple Sleep Latency Test (MSLT)
- Cerebrospinal fluid examinations
- HLA typing
Which drugs are considered first-line, second-line, and third-line options for treating daytime sleepiness in narcolepsy?
- First-line: modafinil, pitolisant, solriamfetol
- Second-line: methylphenidate
- Third-line: combination of drugs or amphetamines
What factors contribute to the socioeconomic burden of CDH?
- Medical comorbidities
- Long-term disability
- High absenteeism
- Work accidents
How have animal studies contributed to our understanding of narcolepsy?
- Face validity for the disorder's phenotype
- Predictive validity of drug effectiveness
- Construct validity related to hypocretin/orexin levels
What is the frequency and incidence of narcolepsy type 1 (NT1)?
- Frequency: 20-50 per million
- Incidence: about 10 per million per year
- Varies by location (lower in Israel, higher in Japan)
What symptoms are targeted by antidepressants in narcolepsy treatment?
- Cataplexy
- Rapid eye movement sleep-associated symptoms
- Disturbed night-time sleep
What is often misinterpreted as excessive daytime sleepiness?
- Lack of energy
- Absence of excessive sleep
How prevalent is fatigue among narcolepsy patients?
- NT1: 76%
- NT2: 85%
- Healthy controls: 24%
What new evidence has emerged regarding narcolepsy and the immune system?
- Association with human leukocyte antigen (HLA)
- Immune-mediated loss of hypocretin neurones
- Low cerebrospinal fluid levels of hypocretin-1
What defines narcolepsy type 1 (NT1) in the diagnostic criteria?
- Daily periods of irrepressible sleep need for at least 3 months
- Cataplexy presence
- Mean sleep latency
How do patient characteristics influence drug selection for narcolepsy treatment?
- Presence and severity of symptoms
- Age and gender
- Birth control methods
- Comorbid conditions
What are the neurophysiological hallmarks of narcolepsy?
- SOREMs occurring within 15-20 min from sleep onset
- Loss of continuity in sleep and wakefulness
- Presence of "dissociated states" during sleep
Describe the clinical phenotypes of narcolepsy.
- Typical cataplexy with biological markers
- Typical cataplexy without biological markers
- Atypical narcolepsy without cataplexy but with biological markers
- Sporadic, familial, or secondary narcolepsy
What is the role of sodium oxybate in narcolepsy treatment?
- Cataplexy
- Disturbed night-time sleep
- Rapid eye movement sleep-associated symptoms
What correlation exists between fatigue and treatment in narcolepsy patients?
- Higher stimulant doses
- Poor response to treatment
- Detrimental effects on nocturnal sleep efficiency
What psychiatric issues are often found in narcolepsy patients?
- Anxiety
- Mild to moderate depression
- Social phobias
- Occurs in 20%-30% of cases
How does excessive daytime sleepiness (EDS) relate to the hypocretin system?
- Dense hypocretin projections to aminergic nuclei
- Impaired activity of these nuclei contributing to EDS
What is the significance of patient education concerning driving in narcolepsy?
- Risks of sleepiness while driving
- Potential dangers at work and in daily life
How do attention and cognitive performances differ in narcolepsy?
- Difficulty in prolonged tasks
- Normal short-term tasks
- Worse scores in complex attention tasks
What cognitive disturbances can occur in narcolepsy?
- Attention problems
- Executive function issues
- Consequence of excessive daytime sleepiness
Describe the ideal management strategy for idiopathic hypersomnia.
- Use of stimulants
- Non-evidence-based approaches
- Regular sleep hygiene
What is the proposed correlation between EDS severity and SOREMs?
- Severity of EDS may correlate with presence of SOREMs
- Naps with REM sleep show more imperative sleepiness
What tools exist for assessing the quality of life in individuals with CDH?
- Medical Outcomes Study 36-item Short Form Health Survey (SF-36)
- Focus on functioning, distress, and personal health evaluations
What anatomical structures are involved in cataplexy?
- Medial medulla and its spinal cord projections
- Hypothalamus, amygdala, and prefrontal cortex
- Pontine sublaterodorsal nucleus (SLD)
How is metabolic disturbance characterized in narcolepsy patients?
- Higher body mass index (BMI) by 10%-20%
- Reduced metabolic rate
- Decreased motor activity
- Increased prevalence of type 2 diabetes
What needs to be considered for effective narcolepsy treatment monitoring?
- Severity of symptoms
- Treatment efficacy
- Self-reported and objective measures
What is the impact of EDS severity on quality of life?
- Lower health-related quality of life (HRQoL)
- Common reports of depressive feelings
What adverse effects are commonly associated with modafinil?
- Headache (13%)
- Nervousness (8%)
- Nausea (5%)
What academic challenges do narcoleptic patients face?
- Poor concentration
- Low speed
- Forgetfulness
- Anxiety about performance
How is pitolisant administered for narcolepsy treatment?
- As a single morning dose
- Doses range from 9-36 mg/day
How does narcolepsy influence job outcomes?
- High dropout rates (25% dropout)
- Lower productivity and employment rates
What is the mechanism of action of modafinil?
- Increasing dopamine concentration
- Blocking the dopamine transporter
- Potential action on several neurotransmitter systems
What relationship exists between early diagnosis and educational achievement in narcolepsy patients?
- Higher levels of education
- Fewer job changes
- Low unemployment rate
What key factors influence the treatment decisions for central disorders of hypersomnolence?
- Severity and persistence of symptoms
- Associated comorbid conditions
- Patient characteristics
How does chronic illness affect life domains in patients?
- Health-related quality of life (HRQoL)
- Daily functioning and social interactions
What are common misconceptions about EDS in narcolepsy patients?
- Laziness
- Drug abuse
- Lack of effort
What economic impacts do CDH impose on patients?
- Increased medical consultations
- Lower employment rates
- More frequent job terminations
Why is awareness of CDH important for patients' educational and work choices?
- Selecting jobs with low risk of sleep-related accidents
- Allowing scheduled naps
- Adjusting school commitments
The question on the page originate from the summary of the following study material:
- A unique study and practice tool
- Never study anything twice again
- Get the grades you hope for
- 100% sure, 100% understanding

















